Heike Biller

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial

Jens M. Hohlfeld, Jens Vogel‐Claussen, Heike Biller et al. · The Lancet Respiratory Medicine · 2018 · 174 citations

Single-centre Trial, Pulmonary Circulation, Advanced Lung Disease +7

Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells

Antje Prasse, C G Georges, Heike Biller et al. · Clinical & Experimental Immunology · 2000 · 124 citations · Full text

Characterization of Exhaled Particles from the Healthy Human Lung—A Systematic Analysis in Relation to Pulmonary Function Variables

Katharina Schwarz, Heike Biller, Horst Windt et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2010 · 122 citations

Genotype-corrected reference values for serum angiotensin-converting enzyme

Heike Biller, Gernot Zissel, Bertram Ruprecht et al. · European Respiratory Journal · 2006 · 79 citations · Full text